Skip to main content

Top Left Menu

  • Careers
  • Media

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Aesthetics
    • Consumer Care
    • Prescription Medicine
    • Global presence
    • Executive Committee
    • Governance
    • Annual Review 2021
  • Skin Stories
  • Skin Science
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • Our ESG roadmap
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
  • Media
  • Careers

Galderma announces positive results in two phase III studies for a novel liquid formulation botulinumtoxinA (RelabotulinumtoxinA) for the treatment of glabellar lines (frown) and lateral canthal lines (crow’s feet)

Press release

Galderma to present extensive new clinical data across its portfolio of neuromodulators, fillers and biostimulators at the IMCAS World Congress 2022

Press release

Cetaphil® debuts global sensitive skin awareness initiative

Press release

Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space

Press release

Galderma to present new clinical data and high patient satisfaction across their portfolio of dermal fillers, collagen biostimulators and liquid neuromodulators at AMWC 2022

Press release

Galderma to highlight latest science and innovation across its product portfolio at the 2022 AAD Annual meeting

Press release

Taro to acquire Alchemee from Galderma

Press release

Karen L. Ling joins Galderma’s Advisory Committee

Press release

Galderma launches Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology® designed to assist with recovery from surgical body procedures

Press release

Galderma successfully completes acquisition of ALASTIN Skincare®

Press release

Pagination

  • Previous page Previous Page
  • Next page Next Page
Subscribe to Global release
  1. Home

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2023

Footer menu 2

  • Terms of use
  • Privacy
  • Cookie notice
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back